WO/2016/075513 SUCTIONING DEVICE FOR LARGE ARTIFICIAL WATER BODIES||WO||19.05.2016|
||PCT/IB2014/065981||CRYSTAL LAGOONS (CURACAO) B.V.||FISCHMANN TORRES, Fernando Benjamin|
The present invention relates to a flexible suctioning device for suctioning floes from the bottom of large artificial water bodies with surfaces larger than 10,000 m and with bottoms covered with plastic liners that do not have centralized filtration systems, and that is able to clean a bottom surface of large artificial water bodies at a surface cleaning rate of 325,000 ft 2 per 24 hours (30,000 m2 per 24 hours) or more, where the bottom surface of the large artificial water bodies can be irregular and sloped, and where the suctioning device is reversible and is supported by a plurality of brushes, comprising first brushes, disposed to provide appropriate support to the suction device and minimize the dispersion and re-suspension of settled floes. The suctioning device is designed in order to concentrate the suction power in a series of suction points, where the suctioning device is connected to an external filtration system that may not be attached to the suctioning device.
WO/2015/099029 INJECTABLE AGENT AND DEPOT FORMATION METHOD||WO||02.07.2015|
||PCT/JP2014/084289||SANTEN PHARMACEUTICAL CO., LTD.||OKI, Kenji|
The purpose of the present invention is to provide a novel injectable agent having an excellent medicinal agent sustained release property.
The injectable agent according to the present invention comprises a medicinal agent, trehalose and gellan gum. It is preferred that the contents of the medicinal agent, trehalose and gellan gum are 0.0001 to 50.00% (w/v), 0.1 to 50.0% (w/v) and 0.01 to 3.00% (w/v), respectively, relative to the total volume of the injectable agent. It is also preferred that the injectable agent can form a depot upon the contact with a phosphate buffer solution or a body fluid (tear fluid, vitreous fluid, etc.).
WO/2015/097713 NOVEL HETEROCYCLIC COMPOUNDS||WO||02.07.2015|
||PCT/IN2014/000704||CADILA HEALTHCARE LIMITED||DESAI, Ranjit, C.|
The present invention relates to novel GPR 40 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
WO/2015/092638 N-CARBAMOYLMETHYL-4(R)-PHENYL-2-PYRROLIDONE POLYMORPHIC FORMS||WO||25.06.2015|
||PCT/IB2014/066849||JSC OLAINFARM||LIEPINS, Vilnis|
The invention is related to N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidone crystalline polymorphic forms and their production methods, as well as to the use of said polymorphic forms for pharmaceutical compositions manufacturing.
WO/2015/091805 QUINAZOLIN-THF-AMINES AS PDE1 INHIBITORS||WO||25.06.2015|
||PCT/EP2014/078475||H. LUNDBECK A/S||KEHLER, Jan|
The present invention provides Quinazolin-THF-amines as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
WO/2015/087156 SYSTEM AND METHOD FOR MAINTAINING WATER QUALITY IN LARGE WATER BODIES||WO||18.06.2015|
||PCT/IB2014/002891||CRYSTAL LAGOONS (CURACAO) B.V.||FISCHMANN TORRES, Fernando Benjamin|
Energy saving installation and method for treating large water bodies wherein the method comprises: (a) applying an effective amount of a flocculent to water in the water body to maintain turbidity of the water below 2 NTU, wherein the flocculent flocculates suspended solids in the water into particles that settle to the bottom of the water body. (b) operating a mobile suctioning device to maintain an increase in the black component of the bottom's colour below 30% based on the CMYK scale, wherein the mobile suction device suctions a portion of water from the bottom of the water body containing settled particles, and wherein the device is capable of cleaning at a surface cleaning rate of 10,000m2/24 hours; (c) filtering the water suctioned by the mobile suction device and returning the filtered water to the water body, wherein the water suctioned by the mobile suction device does not exceed 10% of the total water volume of the water body in a 24 hour interval; and (d) operating a degreasing system to maintain a surface water layer having less than about 20 mg/L of floating greases, wherein greases from a surface water flow into the degreasing system are removed by a separation unit comprising a degreaser and the treated water is returned to the water body.
WO/2015/075598 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS||WO||28.05.2015|
||PCT/IB2014/065935||PFIZER INC.||BEHENNA, Douglas Carl|
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Q, G, ring A, ring B, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, and m are defined herein. The novel purine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.
WO/2015/077174 ADDITIVES FOR DRAG REDUCING POLYMERS||WO||28.05.2015|
||PCT/US2014/065897||LUBRIZOL SPECIALTY PRODUCTS, INC.||OLECHNOWICZ, Michael R.|
A method of forming a drag reducing polymer formulation. The method begins by forming a drag reducing polymer. A hydrocarbon additive is then incorporated with the drag reducing polymer to form a drag reducing polymer formulation. The drag reducing polymer formulation is then used as a drag reducer in hydrocarbon pipelines.
WO/2015/071806 SLOW-RELEASE SOLID ORAL COMPOSITIONS||WO||21.05.2015|
||PCT/IB2014/065852||GNOSIS SPA||GIOVANNONE, Daniele|
The present invention relates to a slow-release solid oral nutraceutical and/or pharmaceutical composition comprising: c) a core containing a donor of methyl groups and at least one pharmaceutically acceptable excipient, and d) an outer coating containing shellac and/or a pharmaceutically acceptable salt thereof, magnesium stearate, and at least one pharmaceutically acceptable excipient. The coating of said solid oral composition allows the donor of methyl groups, preferably SAMe and/or a pharmaceutically acceptable salt thereof, to cross intact the gastric barrier and release the same in a continuous and complete manner along the entire digestive tract.
WO/2015/068042 FLOATING LAKE AND METHODS OF TREATING WATER WITHIN THE FLOATING LAKE||WO||14.05.2015|
||PCT/IB2014/002991||CRYSTAL LAGOONS (CURACAO) B.V.||FISCHMANN, Fernando, Benjamin|
The present invention relates to floating lakes and to the treatment of the water in such lakes. The present invention further relates to large floating lakes that can be installed within a natural or artificial water body to improve water conditions that are unsuitable for recreational uses. The floating lake can be provided with a chemical application system; a filtration system including a mobile suctioning device and filters; a skimmer system, and optionally a coordination system.